Although the incidence of polio acute flaccid paralysis (AFP) has decreased in India, the nonpolio AFP (NPAFP) rate has increased. Nationwide, the NPAFP rate is 11.82 per 100 000 population, whereas the expected rate is 1 to 2 per 100 000 population.
Andre 5.1.1
A few questions:
Assuming for the sake of argument that the apparent increase in non-polio acute flaccid paralysis is in fact due to the version of polio vaccine being used in India being the cheaper of vaccines available (this assumption is by no means a clear conclusion from the available evidence), do you think this outcome is worse than the outcome would have been from not vaccinating and letting polio run rampant?
Date Time
Changes to human behaviour critical to cut pandemic risk
Researchers from The University of Western Australia say global consumption and people’s interconnectedness have created conditions for pandemics to thrive. The scientists have released a report with recommendations for policy makers to help decrease future risks.
The report highlights that unless we make drastic changes to behaviour, policy and government interventions and the enforcement of regulations, pandemics will increase in future.
The project led by Dr Kirsten Martinus, from UWA’s Department of Geography and Planning, drew on the research expertise of Dr Marit Kragt from UWA’s School of Agriculture and Environment, Dr Natasha Pauli from the School of Agriculture and Environment and Department of Geography and Planning and Professor Jane Heyworth from UWA’s School of Population and Global Health.
Scientists and government pushing for ways to make mRNA vaccines here
Normal text size
Advertisement
The federal government is working with the biotech industry on ways to establish large-scale mRNA vaccine manufacturing in Australia as a group of senior scientists work on a parallel plan to enable local production of the cutting-edge jabs.
The mRNA coronavirus vaccines from Pfizer and Moderna yielded remarkably strong results in clinical trials and are expected to be much easier to reconfigured to cover new viral variants than more conventional inoculations such as AstraZeneca’s, which is being made in Australia by CSL.
Harry Al-Wassiti (L) and Colin Pouton are working on a COVID-19 vaccine at Monash University.
The mathematics of shuffling maths.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from maths.org Daily Mail and Mail on Sunday newspapers.
Health chief defends AstraZeneca vaccine as some question Australia s COVID-19 vaccine strategy
WedWednesday 3
updated
ThuThursday 4
FebFebruary 2021 at 4:56am
By the end of February, the first phase of vaccine rollouts will begin in Australia, but some experts are now questioning the choice of vaccines and the negotiations surrounding them.
(
Share
Print text only
Cancel
Questions have been raised about Australia s reliance on the Oxford-AstraZeneca vaccine in the fight against COVID-19, with calls for the Federal Government to secure more doses of higher-efficacy jabs instead.
The criticism prompted the nation s former chief medical officer, now head of the Department of Health, Professor Brendan Murphy, to defend the AstraZeneca vaccine, telling 7.30 he would be very pleased to have it .